( NASDAQ-NMS:VVUS )

News from vivus, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Mar 31, 2011, 06:45 ET Long-Term Data on QNEXA® to be Presented at The American College of Cardiology Annual Meeting

VIVUS, Inc. (Nasdaq: VVUS) today announced that data on QNEXA®, its investigational drug candidate, will be featured in a poster presentation...


Mar 29, 2011, 06:45 ET VIVUS to Present at the 10th Annual Needham Healthcare Conference

VIVUS, Inc. (Nasdaq: VVUS) today announced that Timothy Morris, chief financial officer, will present an overview of the company at the 10th Annual...


Feb 28, 2011, 16:00 ET VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results

VIVUS, Inc. (Nasdaq: VVUS), a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today...


Feb 25, 2011, 06:45 ET VIVUS to Present at Three Upcoming Investor Conferences in March

VIVUS, Inc. (Nasdaq: VVUS) today announced that Timothy Morris, chief financial officer, will present an overview of the company at three...


Jan 21, 2011, 06:59 ET VIVUS Provides Regulatory Update on QNEXA NDA

VIVUS, Inc. (Nasdaq: VVUS) today announced that it held an End-of-Review meeting with the Food and Drug Administration (FDA) for the New Drug...


Jan 05, 2011, 07:00 ET VIVUS to Present at the 2011 JP Morgan Healthcare Conference

VIVUS, Inc. (Nasdaq: VVUS) today announced that Leland Wilson, chief executive officer, will present an overview of the company at the 29th Annual...


Dec 20, 2010, 06:45 ET VIVUS Files European Marketing Authorization Application for QNEXA® in the Treatment of Obesity

VIVUS, Inc. (Nasdaq: VVUS) today announced that the company filed a Marketing Authorization Application (MAA) with the European Medicines Agency...


Dec 14, 2010, 06:45 ET VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA®

VIVUS, Inc. (Nasdaq: VVUS) today announced that the company, as part of its continuing effort to secure regulatory approval for QNEXA® in the...


Dec 06, 2010, 07:00 ET VIVUS Announces Positive Results From Long-Term Phase 3 Study of Avanafil in Erectile Dysfunction

VIVUS, Inc. (Nasdaq: VVUS) today announced positive results from TA-314, a phase 3 pivotal open-label safety study of avanafil, an investigational...


Dec 03, 2010, 07:00 ET VIVUS to Present at Two Upcoming Investor Conferences

VIVUS, Inc. (Nasdaq: VVUS) today announced that senior management will present an overview of the company at two investment conferences during the...


Nov 15, 2010, 16:15 ET Data on VIVUS' QNEXA to be Presented at the American Heart Association Scientific Sessions 2010

VIVUS, Inc. (Nasdaq: VVUS) today announced that data on QNEXA®, an investigational drug candidate, will be featured in a poster presentation...


Nov 08, 2010, 16:00 ET VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results

VIVUS, Inc. (Nasdaq: VVUS), a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today...


Nov 08, 2010, 06:30 ET VIVUS Announces Closing of MUSE Sale

VIVUS, Inc. (Nasdaq: VVUS) today announced that it has closed the sale of its MUSE business to Meda.  Under the purchase agreement, Meda...


Nov 04, 2010, 07:15 ET VIVUS to Present at Two Upcoming Investor Conferences

VIVUS, Inc. (Nasdaq: VVUS) today announced that Timothy Morris, chief financial officer, will present an overview of the company at two...


Oct 28, 2010, 20:33 ET FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA®

VIVUS, Inc. (Nasdaq: VVUS) announced today that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA)...


Oct 21, 2010, 06:45 ET Data on VIVUS' QNEXA to Be Featured in Two Presentations at the First International Diabetes and Obesity Forum

VIVUS, Inc. (Nasdaq: VVUS) today announced that data on QNEXA®, an investigational drug candidate, will be featured in two oral presentations...


Oct 07, 2010, 06:45 ET Data on VIVUS' QNEXA to be Presented in Six Posters at The Obesity Society's Annual Meeting

VIVUS, Inc. (Nasdaq: VVUS) today announced that data on QNEXA®, an investigational drug candidate, are highlighted in six poster presentations...


Oct 04, 2010, 09:55 ET VIVUS Announces Sale of MUSE Assets to Meda

VIVUS, Inc. (Nasdaq: VVUS) today announced that it has entered into an asset purchase agreement with Meda - an international specialty pharma...


Sep 21, 2010, 16:18 ET VIVUS Announces QNEXA Presentations at the European Association for the Study of Diabetes (EASD) Annual Meeting

VIVUS, Inc. (Nasdaq: VVUS) today announced that data on QNEXA(R), an investigational drug candidate, are featured in two poster presentations at...


Sep 21, 2010, 06:45 ET New Long-Term Data on QNEXA® Show Significant and Sustained Weight Loss of Greater Than 10% Over Two Years

VIVUS, Inc. (Nasdaq: VVUS) today announced positive top-line results from a two-year study of QNEXA® (phentermine/topiramate) Controlled...